advertisement
Eye and vision (London, England) 23
Showing records 1 to 23 | Display all abstracts in Eye and vision (London, England)106271 Dynamic analysis of iris changes and a deep learning system for automated angle-closure classification based on AS-OCT videos
Hao L
Eye and vision (London, England) 2022; 9: 41
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
He JN
Eye and vision (London, England) 2022; 9: 37
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Li S
Eye and vision (London, England) 2022; 9: 44
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
He JN
Eye and vision (London, England) 2022; 9: 37
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Guo L
Eye and vision (London, England) 2022; 9: 44
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
Ng TK
Eye and vision (London, England) 2022; 9: 37
106271 Dynamic analysis of iris changes and a deep learning system for automated angle-closure classification based on AS-OCT videos
Hu Y
Eye and vision (London, England) 2022; 9: 41
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhou P
Eye and vision (London, England) 2022; 9: 44
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
Lu SY
Eye and vision (London, England) 2022; 9: 37
106271 Dynamic analysis of iris changes and a deep learning system for automated angle-closure classification based on AS-OCT videos
Xu Y
Eye and vision (London, England) 2022; 9: 41
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
Tam POS
Eye and vision (London, England) 2022; 9: 37
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Tang J
Eye and vision (London, England) 2022; 9: 44
106271 Dynamic analysis of iris changes and a deep learning system for automated angle-closure classification based on AS-OCT videos
Fu H
Eye and vision (London, England) 2022; 9: 41
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
Chan PP
Eye and vision (London, England) 2022; 9: 37
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Wang Z
Eye and vision (London, England) 2022; 9: 44
106271 Dynamic analysis of iris changes and a deep learning system for automated angle-closure classification based on AS-OCT videos
Miao H
Eye and vision (London, England) 2022; 9: 41
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
Tham CC
Eye and vision (London, England) 2022; 9: 37
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhang L
Eye and vision (London, England) 2022; 9: 44
106271 Dynamic analysis of iris changes and a deep learning system for automated angle-closure classification based on AS-OCT videos
Zheng C; Liu J
Eye and vision (London, England) 2022; 9: 41
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhao M
Eye and vision (London, England) 2022; 9: 44
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
Pang CP
Eye and vision (London, England) 2022; 9: 37
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Qu J
Eye and vision (London, England) 2022; 9: 44
105963 Genetic association of ANGPT2 with primary open-angle glaucoma
Chen LJ; Chu WK
Eye and vision (London, England) 2022; 9: 37